Tag Archives: SCS

Best Warren Buffett Stocks To Invest In 2019

Tim Melvin

Corporate raiders and plunderers might’ve dominated the public’s image of finance in the late 1980s, but the private equity firms behind the image were making pots of money…

I am very fond of pots of money, so I began to drill down and investigate the secret sauce used to build massive wealth.

I really started to focus on how private equity firms were investing their client’s money. It was the height of the Michael Milken-led leveraged buyout boom, and private equity investors were at the forefront of the activity.

What....More>>>

Hot Stocks To Invest In Right Now

The State of the Union address did not help stocks on Wednesday, but on the plus side, it did not deal a blow to the markets either. As of now, stocks are simply chopping and consolidating, pondering the next move as major U.S. indices flirt with an overbought condition. Let’s check out a few must-see stock trades for Thursday.

Must-See Stock Trades #1: Disney

Hot Stocks To Invest In Right Now: Renewable Energy Group, Inc.(REGI)

Advisors’ Opinion:

[By Lisa Levin]

Monday morning, the energy shares rose 0.86 percent. Meanwhile, top gainers in the sector included....More>>>

Best Warren Buffett Stocks To Watch For 2019

Warren Buffett’s penchant for picking great stocks for Berkshire Hathaway’s (NYSE:BRK-A) (NYSE:BRK-B) portfolio makes his quarterly stock picks must-know news for every long-term investor. Luckily, Buffett is required to file a 13F report with the Securities and Exchange Commission every quarter showing what he’s been buying, and that makes following in his footsteps easier. Last quarter, his top buys were U.S. Bancorp (NYSE:USB), Apple, Inc. (NASDAQ:AAPL), and Teva Pharmaceutical Industries (NYSE:TEVA). Should you buy these stocks for your portfolio, too?

Bigger....More>>>

Top 10 Heal Care Stocks To Invest In Right Now

Just how blue are the skies for Nuance?

Nuance (NASDAQ:NUAN) reported the results of its quarter and fiscal 2016 year-end last Thursday. Talk about saving the best for last, the company’s results marked the end of the calendar Q3 reporting season, and based on the way I keep score, the results were the best relative to prior expectations of all of the companies that I track. Not on the headline numbers, although they were a modest beat, but on bookings, which were by far the best performance relative to expectations in the IT space last quarter. 45% growth in bookings is not something....More>>>

Top 5 Value Stocks To Buy For 2018

Oppenheimer set a $120.00 target price on Neurocrine Biosciences (NASDAQ:NBIX) in a report published on Monday morning. The brokerage currently has a buy rating on the stock. Oppenheimer also issued estimates for Neurocrine Biosciences’ FY2021 earnings at $7.03 EPS and FY2022 earnings at $7.88 EPS.

Several other research analysts have also commented on the company. ValuEngine raised Neurocrine Biosciences from a hold rating to a buy rating in a research report on Monday, April 2nd. BidaskClub downgraded Neurocrine Biosciences from a strong-buy rating to a buy rating in a research....More>>>